In TMEs, aerobic glycolysis is a central metabolic program associated with the activation of innate (dendritic cells, macrophages, and neutrophils) and adaptive (CD8+ and CD4+ T cells, B cells) immune cells, the limitation of which compromises effector functions and the anti-tumor effects of these cells [7]. This evidence concerns the gene CD8A and neoplasm.